| |
|
|
|
AC Immune S.A.  
|
|
4.85 0.05 (0.01%) |
09-24 16:00 |
|
Open: |
4.8 |
Pre close: |
4.8 |
Target:
|
8.78
|
|
High: |
5.2 |
Low: |
4.8 |
Resistance:
|
7.52
9.20
|
|
Volume: |
1,971,197 |
Market Cap: |
348M |
Support:
|
4.80
3.99
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.25
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
7.80 |
Signal(12,26,9): |
0.23 |
|
MA(100): |
7.28 |
Stochastic Oscillator |
%K(14,3):
|
26.73 |
|
MA(250): |
7.26 |
%D(3): |
55.73 |
|
Average Volume(K) |
3-Month: |
119556
|
52-Week |
High:
|
13.00 |
|
10-Days: |
96563 |
Low: |
4.07 |
|
RSI |
RSI(14):
|
26.13  |
Change(%): |
-1.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-9.4 |
Shares Out. (M) |
71.74 |
|
EPS Est. Current Year |
-0.620 |
Return on Assets (ttm) |
-5.2 |
Shares Float (M) |
26.89 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
47.90 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
-15.4 |
% Held by Institutions |
26.78 |
|
Forward EPS |
-0.837 |
Gross Profit (p.s.) |
0.845 |
Shares Short (K) |
1540 |
|
Book Value (p.s.) |
2.990 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.82 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.62 |
|
Profit Margin |
-51.20 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
